P/E ratio for Accelerate Diagnostics (AXDX)
P/E ratio as of September 2023 (TTM): -0.6557
According to Accelerate Diagnostics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.655654. At the end of 2021 the company had a P/E ratio of -4.06.
P/E ratio history for Accelerate Diagnostics from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -4.06 | -23.79% |
| 2020 | -5.32 | -50.55% |
| 2019 | -10.8 | 46.62% |
| 2018 | -7.34 | -67.5% |
| 2017 | -22.6 | 40.42% |
| 2016 | -16.1 | -25.1% |
| 2015 | -21.5 | -20.92% |
| 2014 | -27.2 | -17.59% |
| 2013 | -33.0 | 352.68% |
| 2012 | -7.28 | -92.34% |
| 2011 | -95.0 | -755.17% |
| 2010 | 14.5 | -138.3% |
| 2009 | -37.9 | 48.63% |
| 2008 | -25.5 | 105.06% |
| 2007 | -12.4 | 58.57% |
| 2006 | -7.83 | -48.43% |
| 2005 | -15.2 | -41.58% |
| 2004 | -26.0 | 91.58% |
| 2003 | -13.6 | -9.52% |
| 2002 | -15.0 | 105.48% |
| 2001 | -7.30 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 34.2 | -5,311.99% | 🇺🇸 USA |
 Becton Dickinson BDX | 47.3 | -7,320.35% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -2,382.70% | 🇺🇸 USA |
 Bruker BRKR | 28.8 | -4,487.92% | 🇺🇸 USA |
 NanoString Technologies NSTG | -0.5367 | -18.14% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -23.9 | 3,547.76% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.